Cancer BiologybioRxiv
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells
M. Tarrado-Castellarnau, C. Foguet, J. Tarrago-Celada…·M. Cascante
This study shows that combining Palbociclib with Telaglenestat prevents acquired resistance in colorectal cancer cells by counteracting metabolic reprogramming.
DOI 10.1038/s41388-025-03495-w